MedShr
Sign InSign Up
Promotion

Earn CPD as you learn

Log in or sign up to start learning

Find out more

Clinical Pharmacology

Clinical Pharmacology

The V-HeFT I: Hydralazine and isosorbide dinitrate reduce mortality in heart failure
CPD
$9.95

The V-HeFT I: Hydralazine and isosorbide dinitrate reduce mortality in heart failure

This is a Module from the Course

Volume 1: General Chronic Disease and Cardiology from 2MM™ The Classics In Medicine
By 2 Minute Medicine®
2 Minute Medicine™
Expected time:10 minutes
Preview
The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide
CPD
$9.95

The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide

This is a Module from the Course

Volume 2: General Chronic Disease and Cardiology from 2MM™ The Classics In Medicine
By 2 Minute Medicine®
2 Minute Medicine™
Expected time:10 minutes
Preview

Interested in becoming a content partner? Learn more.

  • MedShr
  • About us
  • Our team
  • Careers
  • Partners
  • Case studies
  • Partner with us
  • Contact us
  • contact@medshr.net
  • Social
  • Connect with MedShr on Facebook
  • Connect with MedShr on Instagram
  • Connect with MedShr on LinkedIn
  • Follow MedShr on X
  • Subscribe to MedShr's YouTube channel

Available on Web, Android, iPhone and iPadGet it on Google PlayDownload on the App Store

© 2026 MedShr. All rights reserved.

  • Privacy policy
  • Terms and conditions

MedShr uses cookies to ensure you get the best experience. Learn more